Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
4.730
+0.180 (3.96%)
Jul 10, 2026, 3:00 PM CST
Market Cap2.43B -26.3%
Revenue (ttm)1.90B -3.0%
Net Income36.13M -42.1%
EPS0.06 -47.9%
Shares Out 534.07M
PE Ratio76.24
Forward PEn/a
Dividend0.07 (1.48%)
Ex-Dividend DateJun 17, 2026
Volume11,632,200
Open4.540
Previous Close4.550
Day's Range4.450 - 4.790
52-Week Range4.330 - 7.530
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Sector Healthcare
Founded 1990
Employees 1,196
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements